Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Jordan

Showing results (371-380 of 682) with videos related to

Pageof 69
Sort By:
The Journal of Chemical Physics|October 12, 2018
Zero-point energy conservation in classical trajectory simulations: Application to H<sub>2</sub>COKin Long Kelvin Lee, Mitchell S Quinn, Stephen J Kolmann, et al.
Annals of Surgery|January 1, 1983
The endorectal pull-through for the management of ulcerative colitis in children and adultsA G Coran, T M Sarahan, T L Dent, et al.
Journal of Neuro-Oncology|May 4, 2019
First report of quality of life in adults with neurofibromatosis 2 who are deafened or have significant hearing loss: results of a live-video randomized control trialChristopher J Funes, Ryan A Mace, Erik A Macklin, et al.
Blood|November 21, 2007
Protein kinase C-associated kinase is required for NF-kappaB signaling and survival in diffuse large B-cell lymphoma cellsSang-Woo Kim, David W Oleksyn, Randall M Rossi, et al.
Science (New York, N.Y.)|August 9, 2020
Rotational resonances in the H<sub>2</sub>CO roaming reaction are revealed by detailed correlationsMitchell S Quinn, Klaas Nauta, Meredith J T Jordan, et al.
Leukemia Research|October 1, 2013
A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemiaDianna S Howard, Jane Liesveld, Gordon L Phillips, et al.
The Journal of Biological Chemistry|December 4, 2020
mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibitionRoberta L Beauchamp, Serkan Erdin, Luke Witt, et al.
Bioorganic & Medicinal Chemistry|October 1, 2016
Design, synthesis and evaluation of anti-CD123 antibody drug conjugatesBin Li, Weiyu Zhao, Xinfu Zhang, et al.
Oncogene|September 12, 2012
Gene signature critical to cancer phenotype as a paradigm for anticancer drug discoveryE R Sampson, H R McMurray, D C Hassane, et al.
Elife|October 19, 2022
Therapeutic resistance in acute myeloid leukemia cells is mediated by a novel ATM/mTOR pathway regulating oxidative phosphorylationHae J Park, Mark A Gregory, Vadym Zaberezhnyy, et al.
Pageof 69

Showing results (371-380 of 682) with videos related to

Sort By:
Pageof 69
The Journal of Chemical Physics|October 12, 2018
Zero-point energy conservation in classical trajectory simulations: Application to H<sub>2</sub>COKin Long Kelvin Lee, Mitchell S Quinn, Stephen J Kolmann, et al.
Annals of Surgery|January 1, 1983
The endorectal pull-through for the management of ulcerative colitis in children and adultsA G Coran, T M Sarahan, T L Dent, et al.
Journal of Neuro-Oncology|May 4, 2019
First report of quality of life in adults with neurofibromatosis 2 who are deafened or have significant hearing loss: results of a live-video randomized control trialChristopher J Funes, Ryan A Mace, Erik A Macklin, et al.
Blood|November 21, 2007
Protein kinase C-associated kinase is required for NF-kappaB signaling and survival in diffuse large B-cell lymphoma cellsSang-Woo Kim, David W Oleksyn, Randall M Rossi, et al.
Science (New York, N.Y.)|August 9, 2020
Rotational resonances in the H<sub>2</sub>CO roaming reaction are revealed by detailed correlationsMitchell S Quinn, Klaas Nauta, Meredith J T Jordan, et al.
Leukemia Research|October 1, 2013
A phase I study using bortezomib with weekly idarubicin for treatment of elderly patients with acute myeloid leukemiaDianna S Howard, Jane Liesveld, Gordon L Phillips, et al.
The Journal of Biological Chemistry|December 4, 2020
mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibitionRoberta L Beauchamp, Serkan Erdin, Luke Witt, et al.
Bioorganic & Medicinal Chemistry|October 1, 2016
Design, synthesis and evaluation of anti-CD123 antibody drug conjugatesBin Li, Weiyu Zhao, Xinfu Zhang, et al.
Oncogene|September 12, 2012
Gene signature critical to cancer phenotype as a paradigm for anticancer drug discoveryE R Sampson, H R McMurray, D C Hassane, et al.
Elife|October 19, 2022
Therapeutic resistance in acute myeloid leukemia cells is mediated by a novel ATM/mTOR pathway regulating oxidative phosphorylationHae J Park, Mark A Gregory, Vadym Zaberezhnyy, et al.
Pageof 69